S58I (p.Ser58Ile) variant of IRS1 (Insulin receptor substrate 1)
S58I (p.Ser58Ile) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
S58I (p.Ser58Ile) variant details
- p.Ser58Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.